Status: Recruiting
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
This specimen collection is designed to obtain whole blood and tumor tissue from subjects diagnosed with cancer for the purpose of the development of a noninvasive liquid biopsy assay using next generation sequencing (NGS).
Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Sequenom, Inc.Updated: Oct 16, 2024Locations: 1
Eligibility criteria
Subject is 18 years of age or older; [+6]
Underwent curative-intent surgery for management of the presently diagnosed tumo... [+3]